Rx-to-OTC Switch

Browse Rx-to-OTC Switch Content

Here are the Federal Register notice summary excerpts that might be of interest to you or others within your organization. Please see notices for complete details. 

Jun 23, 2021

Now from coast-to-coast, it is once again legal to purchase cold and allergy medicines containing the decongestant pseudoephedrine (PSE) over-the-counter (OTC). In a major victory for consumers, Oregon has repealed a 15-year-old law that banned OTC sales of certain medicines for colds and allergies containing PSE.

Jun 17, 2021

At a June 6 hearing on the FY 2022 FDA Budget, Senate Agriculture-FDA Appropriations Subcommittee Ranking Member, Senator John Hoeven (R-N.D.) asked Acting FDA Commissioner Janet Woodcock about delays with the Non-Prescription Safe Use Regulatory Expansion (NSURE) final rule.

Jun 16, 2021

CHPA congratulates Patrizia Cavazzoni on her recent appointment as director of FDA’s Center for Drug Evaluation and Research (CDER).

Apr 13, 2021

CHPA’s “Insights with Impact” series features Cindy Sanders, Co-Publisher/Managing Editor of Nashville Medical News, who discusses the growing interest in over-the-counter access to oral contraceptives.

Jan 8, 2021

Cindy Sanders discusses a recent study examining the growing interest in OTC access to oral contraceptives.

Jan 8, 2021

The Senate HELP Committee made a strong bipartisan move to modernize the regulatory system overseeing most OTC medicines by approving S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act by voice vote.

Oct 31, 2019

CHPA issued the following statement today following the introduction of S. 2740, the Over-the-Counter Monograph Safety, Innovation, and Reform Act, sponsored by Senators Johnny Isakson (R-Ga.) and Bob Casey (D-Pa.).

Oct 30, 2019

Filter Results